Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Cash Flow Reinvestment Rate
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $43.17 Million (capex $43.17 Million ) from operating cash flow of $130.31 Million. Explore AMRX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Amneal Pharmaceuticals, Inc. Class A Common Stock across 12 annual periods. Also explore Amneal Pharmaceuticals, Inc. Class A Com (AMRX) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Year-by-year capital reinvestment analysis for Amneal Pharmaceuticals, Inc. Class A Common Stock. For live market cap and broader valuation context, see market cap of Amneal Pharmaceuticals, Inc. Class A Com.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | $70.06 Million | $339.99 Million | $70.06 Million | ▼ -55.9% |
| 2024 | 0.47x | $137.99 Million | $295.10 Million | $74.99 Million | ▲ +16.8% |
| 2023 | 0.40x | $138.38 Million | $345.58 Million | $69.19 Million | ▼ -90.2% |
| 2022 | 4.07x | $264.90 Million | $65.10 Million | $90.59 Million | ▲ +306.8% |
| 2021 | 1.00x | $241.91 Million | $241.82 Million | $47.73 Million | ▼ -0.1% |
| 2020 | 1.00x | $379.38 Million | $379.00 Million | $61.84 Million | ▼ -98.5% |
| 2019 | 68.63x | $117.01 Million | $1.71 Million | $97.43 Million | ▲ +3380.0% |
| 2018 | 1.97x | $493.47 Million | $250.23 Million | $97.09 Million | ▲ +117.0% |
| 2017 | 0.91x | $212.82 Million | $234.19 Million | $114.27 Million | ▼ -58.0% |
| 2016 | 2.17x | $249.21 Million | $115.06 Million | $124.61 Million | ▲ +93.5% |
| 2015 | 1.12x | $117.38 Million | $104.88 Million | $117.38 Million | ▲ +58.3% |
| 2014 | 0.71x | $79.38 Million | $112.26 Million | $79.38 Million | — |